摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Norepinephrine d-bitartrate | 69815-49-2

中文名称
——
中文别名
——
英文名称
Norepinephrine d-bitartrate
英文别名
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol;2,3-dihydroxybutanedioic acid;hydrate
Norepinephrine d-bitartrate化学式
CAS
69815-49-2
化学式
C12H19NO10
mdl
——
分子量
337.28
InChiKey
LNBCGLZYLJMGKP-JZGIKJSDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    102-105 °C
  • 比旋光度:
    -46 º (c=0.5, HCl)
  • 溶解度:
    在水中的溶解度50 mg/mL,澄清

计算性质

  • 辛醇/水分配系数(LogP):
    -2.86
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    203
  • 氢给体数:
    9
  • 氢受体数:
    11

安全信息

  • 安全说明:
    S45
  • 危险类别码:
    R26/27/28
  • WGK Germany:
    3
  • 海关编码:
    2922210000

SDS

SDS:218437c7f469c626f7273e76124d59e3
查看

制备方法与用途

用途 
肾上腺素受体激素药。

文献信息

  • PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION
    申请人:BAXTER INTERNATIONAL INC.
    公开号:US20210275470A1
    公开(公告)日:2021-09-09
    A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.
  • [EN] PACKAGED, SEALED CONTAINER SYSTEM FOR STABLE STORAGE OF AN OXYGEN SENSITIVE PHARMACEUTICAL FORMULATION<br/>[FR] SYSTÈME DE RÉCIPIENT SCELLÉ CONDITIONNÉ DE STOCKAGE STABLE DE FORMULATION PHARMACEUTIQUE SENSIBLE À L'OXYGÈNE
    申请人:BAXTER INT
    公开号:WO2021178946A1
    公开(公告)日:2021-09-10
    A packaged, sealed container system for stable storage of a formulation of an oxygen-sensitive pharmaceutical compound, the packaged, sealed container system comprising a primary container including therein a formulation of an oxygen-sensitive pharmaceutical compound, a secondary outer container comprising a first flexible sheet layer, an opposing second flexible sheet layer, and a seal disposed along a common peripheral edge of the first and second flexible sheet layers, such that the primary container is disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. An oxygen scavenger is also disposed between and enclosed by the first and second flexible sheet layers of the secondary outer container. The oxygen scavenger is in fluid communication with the contents of the primary container.
查看更多